Skip to main content

Table 4 Multivariate analysis of factors affecting OS and DFS

From: Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma

 

OS

 

DFS

HR

95.0% CI

P

HR

95.0% CI

P

B symptoms

4.55

1.21–16.96

0.02*

Bulky disease

1.22

0.24-6.06

0.8

Bulky disease

0.66

0.2–2.18

0.5

CD68

0.88

IPS ≥ 3

3.55

1.95–10.521

0.02*

CD68 (score II)

0.83

0.12–5.8

0.85

CD163

0.003*

CD68 (score III)

0.36

0.007–19.6

0.62

CD163 (score II)

1.78

0.41–7.74

0.44

CD163

0.3

CD163 (score III)

9.39

2.19–40.22

0.003*

CD163 (score II)

2.0

0.3–13.1

0.47

  

CD163 (score III)

25.5

0.41–1571.7

0.12

  1. OS overall survival, DFS disease-free survival, HR hazard ratio, CI confidence interval, IPS International Prognostic score